Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Time codes:
  • 03:45

    Comorbidity and diagnosis

  • 07:26

    Pathogenesis and treatment

  • 11:05

    Examples of behavior of children with ADHD

  • 24:27

    Treatment of ADHD

  • 29:57

    The effectiveness of Mexidol®

  • 35:44

    Safety and effectiveness

  • 46:02

    ADHD and its connection with computer dependence

  • 53:25

    Diagnosis and treatment of ADHD

  • 01:06:33

    The effect of ADHD on school academic performance

  • 01:13:22

    Hypoxia and ADHD

  • 01:15:45

    The mechanism of action of the drug Mexidol®

  • 01:21:00

    Recommendations for the use of Mexidol

  • 01:34:11

    Sports and ADHD

  • 01:37:55

    Problems with studies and ADHD

  • 01:41:06

    Drug therapy and ADHD

Grechany Severin Vyacheslavovich - Doctor of Medical Sciences, Associate Professor, Head of the Department of Psychiatry and Narcology of the Federal State Budgetary Educational Institution of Higher Education St. Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation

Natalya Yuryevna Suvorinova , PhD, Associate Professor of the L.O. Badalyan Department of Neurology, Neurosurgery, and Medical Genetics, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation; Neurologist, Clinical Diagnostic Center, Russian Children's Clinical Hospital

Announcement:

The syndrome of attention deficit and hyperactivity (ADHD) is a common clinical disorder in children and can manifest itself in the form of impaired attention, manifestations of hyperactivity and impulsiveness. ADHD should be differentiated with other conditions, such as behavior disorder, anxiety disorders, separation anxiety, social alarm and others. ADHD has a complex pathogenesis associated with genetic and biological factors. The approach to treatment requires an interdisciplinary assessment and should include safe drugs aimed at reducing oxidant stress and protecting brain cells from free radicals. Drug treatment using the drug Mexidol® showed high effectiveness in the treatment of ADHD in children.

Block of articles on this topic

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

Registered on ClinicalTrials 

 

N.N. ZAVADENKO1, N.Yu. SUVORINOVA1, T.T. BATYSHEVA2, O.V. BYKOVA2, A.N. PLATONOVA2, D.D. GAYNETDINOVA3, E.V. LEVITINA4, V.V. MASHIN5, I.N. VAKULA6, N.E. MAKSIMOVA7

1Pirogov Russian National Research Medical University, Moscow, Russia;
2Scientific and Practical Center for Child Psychoneurology, Moscow Department of Health, Moscow, Russia;
3Kazan State Medical University, Kazan, Russia;
4Tyumen State Medical University, Tyumen, Russia;
5Ulyanovsk State University, Ulyanovsk, Russia;
6Center for Professional Therapy, Krasnodar, Russia.

7FSBEI in the Tver State Medical University, Tver, Russia

 

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2022, Vol. 122, No. 4

The possibility of using Mexidol in neuropediatrics

Authors:
N.N. ZAVADENKO, N.YU. SUVORINOVA, A.N. ZAVADENKO

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The course of school adaptation in children with syndrome of attention deficiency with hyperactivity against the background of the use of Mexidol

Authors:
I.S. POTAPOVA, N.V. KHROMINA, M.V. PROTOPOPOVA

Original and reproduced drugs: what do the clinician need to know?

Author:
A.V. SHCHULKIN, A.A. FILIMONOVA
Federal State Budgetary Educational Institution of Higher Education “Ryazan State Medical University” of the Ministry of Health of the Russian Federation, Ryazan, Russia

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com